TrialBone marrow transplantation2014

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.

M Koenigsmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.